92 related articles for article (PubMed ID: 16582871)
21. Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer.
Marshall M; Solomon S; Lawrence Wickerham D
Clin Genet; 2009 Nov; 76(5):427-30. PubMed ID: 19796187
[TBL] [Abstract][Full Text] [Related]
22. No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.
Rashid MU; Torres D; Zaidi A; Rasheed F; Sultan F; Shakoori AR; Amin A; Hamann U
Breast Cancer Res Treat; 2008 Jan; 107(1):155-6. PubMed ID: 18043900
[No Abstract] [Full Text] [Related]
23. Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy. Analysis of two cases, literature review and surgical implications.
Morice P; Pautier P; Delaloge S; Spatz A; Chompret A
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):251-4. PubMed ID: 15063971
[TBL] [Abstract][Full Text] [Related]
24. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
Spannuth WA; Thaker PH; Sood AK
Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
26. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.
Brozek I; Ochman K; Debniak J; Morzuch L; Ratajska M; Stepnowska M; Stukan M; Emerich J; Limon J
Gynecol Oncol; 2008 Feb; 108(2):433-7. PubMed ID: 17997147
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
Russo A; Calò V; Agnese V; Bruno L; Corsale S; Augello C; Gargano G; Barbera F; Cascio S; Intrivici C; Rinaldi G; Gulotta G; Macaluso M; Surmacz E; Giordano A; Gebbia N; Bazan V
Breast Cancer Res Treat; 2007 Nov; 105(3):267-76. PubMed ID: 17221156
[TBL] [Abstract][Full Text] [Related]
28. BCoR-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract][Full Text] [Related]
29. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
Hartikainen JM; Kataja V; Pirskanen M; Arffman A; Ristonmaa U; Vahteristo P; Ryynänen M; Heinonen S; Kosma VM; Mannermaa A
Clin Genet; 2007 Oct; 72(4):311-20. PubMed ID: 17850627
[TBL] [Abstract][Full Text] [Related]
30. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Torres D; Rashid MU; Gil F; Umana A; Ramelli G; Robledo JF; Tawil M; Torregrosa L; Briceno I; Hamann U
Breast Cancer Res Treat; 2007 Jun; 103(2):225-32. PubMed ID: 17080309
[TBL] [Abstract][Full Text] [Related]
31. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects.
Evers B; Jonkers J
Oncogene; 2006 Sep; 25(43):5885-97. PubMed ID: 16998503
[TBL] [Abstract][Full Text] [Related]
32. Genetic counseling for women with breast cancer: the importance of evaluating the spouse.
Allweis TM; Sagi M; Peretz T
Clin Genet; 2004 Dec; 66(6):573-4. PubMed ID: 15521992
[No Abstract] [Full Text] [Related]
33. The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.
Sundararajan S; Ahmed A; Goodman OB
Clin Adv Hematol Oncol; 2011 Oct; 9(10):748-55. PubMed ID: 22252577
[TBL] [Abstract][Full Text] [Related]
34. BRCAPAP: feasibility of clinical BRCA testing on liquid-based cervical cytology: implications for biomarker development.
Muller CY; Schorge JO; Tomlinson GE; Ashfaq R
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1534-7. PubMed ID: 15342457
[TBL] [Abstract][Full Text] [Related]
35. [Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases].
Badora A; Kaleta B; Nowara E; Sikora-Jopek M; Budryk M; Smok-Ragankiewicz A
Ginekol Pol; 2013 Oct; 84(10):892-6. PubMed ID: 24273914
[TBL] [Abstract][Full Text] [Related]
36. The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers.
Friedenson B
BMC Cancer; 2007 Aug; 7():152. PubMed ID: 17683622
[TBL] [Abstract][Full Text] [Related]
37. Mother still knows best: cancer-related gene mutations, familial privacy, and a physician's duty to warn.
Brownrigg A
Fordham Urban Law J; 1999 Jan; 26(2):247-79. PubMed ID: 16437785
[No Abstract] [Full Text] [Related]
38. BRCA-related ovarian carcinoma.
Rubin SC
Cancer; 2003 May; 97(9):2127-9. PubMed ID: 12712461
[No Abstract] [Full Text] [Related]
39. A 12-year experience at a tertiary hospital on patients with multiple primary malignant neoplasms.
Papaconstantinou I; Mantzos DS; Asimakoula K; Michalaki V; Kondi-Pafiti A
J BUON; 2015; 20(1):332-7. PubMed ID: 25778335
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary cancer syndromes in gynecology: what the practitioner needs to know!].
Kuschel B; Köchli OR; Niederacher D; Müller H; Beckmann MW
Schweiz Med Wochenschr; 2000 Mar; 130(10):362-75. PubMed ID: 10763214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
